Mesh Suture, Inc. Achieves Key Regulatory Approvals
Mesh Suture, Inc. has successfully attained significant regulatory milestones that will improve the accessibility of DURAMESH™, its cutting-edge surgical closure solution. This achievement underscores the company's dedication to providing safe and compliant medical technologies aligned with international standards.
Innovative Technology Meets Stringent Standards
DURAMESH™ has now met the requirements set forth by both the European Union Medical Device Regulation (EU MDR) and the Medical Device Single Audit Program (MDSAP). These certifications not only allow the product to be marketed in the European Union but also facilitate compliance across key international markets, including the United States, Canada, Brazil, and Australia.
Benefits of DURAMESH™ in Surgical Procedures
This advanced mesh suture technology incorporates a large-pore, non-absorbable polypropylene design that focuses on effective force distribution and tissue integration. As a result, it provides a robust solution for surgical repairs that actually strengthens over time. Published studies indicate that DURAMESH™ leads to fewer early complications compared to traditional suturing methods, making it an appealing choice for surgeons worldwide.
Enhanced Product Assurance
"Receiving both MDR and MDSAP certifications reflects our unwavering commitment to quality and our global mission to transform surgical closure methods," commented Gregory Dumanian, Founder and Chief Medical Officer of Mesh Suture, Inc. "DURAMESH™ embodies our innovative efforts, as it is designed to deliver more dependable surgical outcomes. We are eager to extend its availability to more healthcare providers and their patients across the globe soon."
Current Availability and Future Directions
Presently, DURAMESH™ is implemented clinically in over 100 hospitals in the U.S. and has expanded its reach to markets in the UK, EU, Turkey, and Mexico. As demand continues to increase, the company is exploring additional opportunities to introduce this innovative product to other regions, enhancing surgical practices internationally.
About Mesh Suture, Inc.
Founded by surgeons dedicated to improving surgical outcomes, Mesh Suture, Inc. has emerged from extensive clinical research in abdominal wall reconstruction and hand tendon surgery. The company is on a mission to eliminate common surgical complications related to failed tissue repairs caused by suture pull-through. To find more about their innovative solutions, visit their website.
Frequently Asked Questions
What is DURAMESH™?
DURAMESH™ is a state-of-the-art mesh suture technology designed for surgical closures, providing enhanced strength and reliability over time.
What certifications has Mesh Suture, Inc. obtained?
Mesh Suture, Inc. has secured both EU MDR and MDSAP certifications, allowing it to market DURAMESH™ in the European Union and other regions.
How does DURAMESH™ compare to standard sutures?
Research indicates that DURAMESH™ has lower early complication rates compared to traditional sutures, making it a preferable option for many surgical applications.
Where is DURAMESH™ available?
DURAMESH™ is currently used in over 100 hospitals across the U.S. and is also available in markets including the UK, EU, Turkey, and Mexico.
What is the mission of Mesh Suture, Inc.?
The mission of Mesh Suture, Inc. is to create innovative surgical solutions that reduce the risk of failed tissue repairs and improve patient outcomes globally.
